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ABSTRACT
Background    Mesenchymal stem cells (MSCs) hold 
promise for application in adult stem cell-mediated re-
generative medicine in bone remodeling and fracture re-
pair. MSCs in vitro can be directed to osteogenic lineage 
by dexamethasone (DEX); however, the use of DEX is 
not practical in clinical settings because of adverse side 
effects such as glucocorticoid-induced osteoporosis. 
For identifying substances that facilitate osteogenesis, 
a monitoring system, which detects the osteogenic dif-
ferentiation stage of MSCs accurately and easily, is re-
quired.
Methods    By focusing on the human osteocalcin (OC) 
gene whose expression profile is described along with 
osteogenic differentiation, we constructed the luciferase 
(Luc) reporter gene driven by the enhancer/promoter 
sequence of the human OC gene (OC-Luc) utilizing a 
mammalian artificial chromosome. Mammalian ar-
tificial chromosome is a suitable platform for loading 
reporter constructs, because of its stable episomal main-
tenance in host cells, transferability into any cell and as-
surance of long-term physiological transgene expression. 
We loaded the OC-Luc on a mammalian artificial chro-
mosome vector engineered from mouse chromosome 
(designated as mouse artificial chromosome, MAC) 
in Chinese hamster ovary cells (OC-Luc/MAC) and 
transferred this into human MSC cells via chromosome 
transfer.
Results    OC-Luc/MAC in human MSC cells are re-
sponsive to positive and negative stimulation by 1 alpha, 
25-dihydroxyvitamin D3 and DEX in differentiation 
stage of MSCs to osteoblasts, reflecting the manner of 
physiological expression.
Conclusion   The OC-Luc/MAC reporter system may 
contribute not only to monitoring the osteogenic dif-
ferentiation stage from MSC but also to identify novel 
osteogenic drugs.
 
Key words    mammalian artificial chromosome; mes-
enchymal stem cells; osteogenic differentiation; osteo-
calcin; reporter assay  
 
In the human body, the skeletal system is one of the 
largest organs, which undergoes remodeling through-
out a person’s lifespan.1 Bone remodeling and fracture 
healing processes are thought to be mediated via os-
teoprogenitors and their ancestors, mesenchymal stem 
cells (MSCs).2 In in vitro studies, a protocol using dexa-
methasone (DEX) is generally accepted for induction 
of osteoblastic differentiation of MSCs.3 In a clinical 
setting, however, the use of DEX is not practical because 
of its adverse side effects such as glucocorticoid-induced 
osteoporosis.4 For successful treatment of bone-loss dis-
orders, chemical compounds and bioactive substances 
that effectively induce bone formation are required.
 In an effort to develop an evaluation system for bone 
remodeling, we previously generated transgenic mice that 
express the luciferase (Luc) reporter gene under the con-
trol of human osteocalcin enhancer/promoter sequences.5 
Osteocalcin (OC) is the main non-collagenous hydroxy-
apatite-binding protein, which is synthesized by osteo-
blasts, odontoblasts and hypertrophic chondrocytes.6 It 
was recognized as a marker of bone formation6 and has 
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been used for detection of osteoblast maturation and 
osteogenic activation.7 Using in vivo bioluminescence 
imaging in the OC-Luc transgenic mice, Luc activity 
was induced throughout their skeletons by administra-
tion of 1,25-dihydroxyvitamin D3 (VD3), which regu-
lates the expression of a number of genes including OC 
in bone cells.8 Furthermore, enhanced bioluminescence 
was observed at the forced radius fracture site reflecting 
progression of the fracture repair. Although the OC-Luc 
transgenic mice would contribute to the final confirma-
tion of drug efficacy selected from hundreds of candi-
dates, an in vitro cell based-assay system is preferable for 
the first screening of high content candidate compounds. 
 Mammalian artificial chromosome vectors have 
been utilized for introduction of genes to recipient cells.9 
As for the origin of their chromosomes, there are two 
kinds of artificial chromosomes, i.e. human artificial 
chromosome (HAC) and mouse artificial chromosome 
(MAC) that have been constructed by chromosome en-
gineering. Since HAC or MAC is maintained as an in-
dependent chromosome in recipient cells, physiological 
regulation of the loaded gene is expected.10 Previously, 
feasibility of cell lineage-specific expression of a trans-
gene by a HAC vector was demonstrated in a human 
MSC line.11 The GFP reporter gene under the regula-
tion of human osteopontin (OPN) promoter loaded on a 
HAC vector was transferred to a human MSC line. OPN 
is another marker of bone formation, whose expression 
is upregulated during maturation of osteoblasts.7 The re-
porter GFP gene in the MSCs was specifically expressed 
in response to osteogenic differentiation induction in co-
ordination with the transcription of endogenous OPN. In 
order to distinguish the osteoblast differentiation process 
from the subsequently occurred maturation processes 
accurately, however, reference reporter system, which 
can trace osteoblast differentiation steps, is required.
 Our aim is setting up a screening platform to iden-
tify compounds that promote or induce differentiation 
of MSCs towards osteoblasts. To this end, we made a 
reporter construct composed of the Luc gene under the 
regulation of OC enhancer/promoter in a MAC vector 
(OC-Luc/MAC).  The MSC lines carrying the OC-Luc/
MAC vector were tested for differentiation ability to 
osteogenic lineage. The induction or restraint of Luc ac-
tivity responding to the already-known positive stimulus 
via VD3 or negative stimulus via DEX treatment was 




A Chinese hamster ovary (CHO) hybrid cell line con-
taining the MAC4 vector10 was maintained in Ham’s 
F-12 nutrient mixture (Wako, Osaka, Japan) supple-
mented with 10 % fetal bovine serum (FBS) (Biowest, 
Kansas, MO). The MAC4 carries an EGFP gene, 
5’HPRT-loxP and a hygromycin gene.10 A mouse A9 
hybrid cell line carrying the MAC4 vector was main-
tained in Dulbecco’s modified Eagle’s medium (DMEM) 
(Wako) supplemented with 10% FBS (Biowest). A 
human immortalized MSC line (hiMSC)12 was main-
tained in DMEM (Wako) supplemented with 10% FBS 
(Biowest). To induce osteogenic differentiation, hiMSC-
derived hybrid cells were fed with osteogenic differen-
tiation medium (LONZA, Basel, Swiss Confederation). 
Cells were maintained at 37 °C with 5% CO2.
Construction of OC-Luc/MAC4 reporter vector
The plasmid pOC-Luc contains firefly Luc gene derived 
from pGL3 (Promega, Madison, WI) driven by 10 kb 
enhancer/promoter region of the human OC gene.5 The 
plasmid v907-3’HPRT/loxP contains the donor loxP site 
and latter half of the HPRT gene. The 14.4 kb AseI/SalI 
fragment containing the Luc gene expression cassette 
was excised from the pOC-Luc plasmid and ligated to 
the compatible AseI/SalI site of the v907-3’HPRT/loxP 
plasmid, yielding the v907 OC-Luc-ins-3’HPRT/loxP. 
Plasmid transfection was carried out by lipofection (Li-
pofectamine 2000, Invitrogen, Carlsbad, CA). Drug re-
sistant colonies obtained by selection with HAT (Sigma-
Aldrich, St.Louis, MO) were picked up and expanded. 
Presence of the sequence on OC-Luc/MAC4 was tested 
by PCR amplification.
Assessment of the hOC/Luc transcription activity 
in CHO/MAC4 cells 
The HAT resistant CHO/MAC4 transfectants were 
plated (1 × 106 cells in 6 well cluster). The next day, cells 
were harvested and lysed in 100 mL lysis buffer (Reporter 
Lysis Buffer, Promega). An aliquot (20 mL) of lysate was 
mixed with 50 mL of Luc solution and measured with 
a luminometer (ALVO MX, Perkin Elmer, Waltham, 
MA). For OC-Luc stimulation study, the HAT resistant 
CHO/MAC4 transfectants were plated (1 × 106 cells 
in 35 mm dish). After treatment with 100 nM VD3 or 
vehicle (DMSO) for 6 h, cells were washed twice with 
phosphate-buffered saline, harvested and lysed in 100 
mL lysis buffer. Lysate (20 mL) was mixed with 50 mL of 
Luc substrate. Luc activity was measured by a luminom-
eter (ALVO MX, Perkin Elmer).  Statistical analysis was 
performed using unpaired Student’s t-test (two-tailed).
Microcell mediated chromosome transfer
The OC-Luc/MAC4 vector was introduced into hiMSCs 
by microcell-mediated chromosome transfer (MMCT) 
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as described previously.13, 14 While microcells prepared 
from the A9 donor cells were fused with hiMSCs using 
47% polyethylene glycol (molecular weight 1000) (Wako) 
and 10% DMSO (Sigma-Aldrich), microcells from the 
CHO donor cells were fused by fusogenic envelope pro-
teins derived from measles virus.14 Microcell hybrids 
were selected with HAT supplement (Sigma-Aldrich) for 
2 weeks.
FISH
Preparation of metaphase chromosome spreads from the 
hybrid cells and fluorescence in situ hybridization (FISH) 
analyses were carried out with standard protocols.13 
Digoxigenin-labelled (Roche, Tokyo, Japan) mouse Cot-
1 DNA (Invitrogen) and biotin-labelled (Roche) hOC-
Luc DNA were used as probes. Chromosomal DNA 
of host cells was counterstained with DAPI (Sigma-
Aldrich). Microscopic images were captured using the 
NIS-Elements system (Nikon, Tokyo). Thirty metaphase 
spreads were observed for each analysis.
Induction of osteogenic differentiation 
The hiMSC cells (3 × 104 cells per well) were seeded in 
6-well plates with growth medium. The next day, me-
dium was changed to differentiation medium (LONZA) 
with or without 10 nM VD3 (Calbiochem, Tokyo). After 
1 week of osteogenesis culture, alkaline phosphatase ac-
tivity (ALP) and luciferase activity were tested.
Detection of ALP activity  
Histochemical staining for ALP activity was carried out 
using a commercially available kit based on naphthol 
Fig. 1. Construction of the OC-Luc/MAC4 reporter vector in donor CHO cells. 
A: A scheme of loading human osteocalcin luciferase (hOC-Luc) into MAC4. MAC4 has an EGFP gene driven by CAG promoter, 5’HPRT 
and acceptor loxP site. The OC-Luc construct is composed of 10 kb human osteocalcin enhancer/promoter sequences with 60 bp of 
the 5’-untranslated sequences (Oc e/p), a luciferase gene (FLuc), the SV40 late polyadenylation signal (pA), the two copies of insulator 
sequences (Ins), 3’HPRT and donor loxP site. The loxP site-specific integration reconstructs the HPRT gene that confers resistance to 
HAT selection. The predicted composition after the loxP site-specific integration is presented at the bottom. The arrows indicate PCR 
primers for detection of the OC-Luc in MAC4. 
B: Presence of the OC-Luc sequences in HAT resistant CHO transfectants was detected by PCR amplification with the primer pairs in-
dicated in A. Size of each amplicon is shown on the right side of the panel. C, CHO/MAC4 genomic DNA; M, size marker; V, vector 
DNA (OC/Luc) used for transfection. 
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AS-MX phosphate and fast red violet B salt (Sigma-
Aldrich). The cultured cells were fixed with citrate 
fixative containing 60% acetone for 30 s at room tem-
perature, rinsed twice with deionized water, treated with 
ALP staining solution for 1 h, rinsed twice with deion-
ized water and then photographed. 
Luciferase assay
Cells were lysed by the addition of 100 mL Reporter 
Lysis Buffer (Promega) in culture vessels, followed by 
a freeze-thaw cycle. Protein concentration of the cell 
lysate was determined by ultraviolet absorption spectro-
photometry. Luc activity was measured using the Pik-
kagene Luciferase Assay System (TOYO B-Net, Tokyo). 
Luc activity was normalized to the protein concentration 
of the cell lysate.
RESULTS
Preparation of the OC-Luc/MAC reporter vector in 
donor CHO cells
Stable maintenance of vectors in host cells is crucial for 
gene delivery studies. We chose the MAC4 vector as a 
platform for the OC-Luc reporter construct, because of 
its stable maintenance in cultured human cells in ad-
dition to mouse cells and transchromosomic mice. 15 It 
carries the GFP gene driven by CAG promoter, which 
allows constitutive expression in various types of cells. 
As a regulatory sequence for the monitoring of OC 
gene expression, an approximately 10 kb genomic DNA 
fragment carrying upstream from the human OC gene 
was chosen (Fig. 1A).  The fragment contains a VD3-re-
sponsive element (VDRE), a GAGA motif and a TATA 
box.5 Co-transfection of the OC-Luc reporter construct 
and the Cre recombinase expression vector pBS185 into 
the CHO cells carrying the MAC4 vector yielded HAT 
resistant colonies after selection culture. Presence of the 
OC-Luc sequence in the HATr cell clones was first test-
ed by PCR amplification of the OC-Luc and MAC4 spe-
cific sequences in genomic DNA of the candidate CHO 
clones (Fig. 1B). The junction sequence between the OC 
promoter and Luc gene was detected in almost all clones 
tested. The sequence spanning the 5’half and 3’half of 
the HPRT gene was also detected, indicating the correct 
site-specific insertion of the OC-Luc construct at the 
loxP site on the MAC4 vector.
 Since the 560 bp minimum promoter of the OC 
gene was previously found to exhibit promoter activity 
Table 1. Summary of FISH analyses in CHO (MAC4-
hOC/Luc) cells
 MAC#  
Clone# 0 1 Integration* Others†
  4 3 13 1 3
10 1 13 3 3
13 0 17 1 2
14 2 13 2 3
17 1 12 3 4
*MAC was integrated into a host chromosome(s).
†Ploidy of the host cells was elevated to tetraploid range.
Fig. 2. Detection of Luc activity in CHO 
cells.
A: Luciferase activity was assessed in 
the HAT resistant CHO transfec-
tants. Measured activities were nor-
malized to those of parental CHO/
MAC4 cells. *P < 0.01: compared to 
the CHO/MAC4 control value. 
B: Response of the OC/Luc to VD3 
was tested in the HAT resisitant 
CHO transfectants. Luciferase activ-
ity was measured after 6 h incuba-
tion with or without 100 nM VD3. 
The measurements were normalized 
to those of cells treated with DMSO. 
*P < 0.01: compared to the DMSO 
control value.  
The bar above each column represents 
SD determined from three independent 
measurements (A and B).
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Fig. 3. Detection and characterization of the OC-Luc/MAC4 vec-
tor in hiMSC hybrid cells.  
A: Representative metaphase spreads of FISH of the hiMSC 
hybrid cells. Digoxigenin-labelled mouse Cot-1 DNA (red) 
was used for detection of the MAC4. Biotin-labelled OC-Luc 
DNA (green) was used for detection of the OC-Luc cassette in 
the MAC4. Chromosomal DNA in the host hiMSC cell was 
counterstained with DAPI (blue). White arrowheads indicate 
the OC-Luc/MAC4 vectors and the insets show enlarged im-
ages of the OC-Luc/MAC4. 
B: ALP staining of the hiMSC hybrid and parental cells. Photo-
graphs of the fixed and stained cells on the culture vessel were 
presented. Upper panels show the cells cultured for 7 days in 
the differentiation induction medium (OD), and lower panels 
show the cells cultured for 7 days in the growth medium (C). 
Red dye staining indicates ALP activity. Scale bar shows 1 
mm.
in CHO cells,16 we next addressed the functional main-
tenance of the OC-Luc reporter activity in CHO cells 
by Luc assay (Fig. 2A). Luc activity was substantially 
increased in CHO (OC-Luc/MAC4) cells, compared to 
the CHO (MAC4) cells in which the OC-Luc construct 
is absent. As the measured Luc activity varied among 
CHO clones, we arbitrarily chose the 5 clones showing 
relatively high Luc activity, and performed FISH analy-
sis to examine the status of the MAC (Table 1). In each 
clone, among 20 metaphase spreads tested, over 60% 
showed diploid CHO karyotype plus one copy of the 
MAC. The retention rate of the MAC in CHO cells was 
high enough for use as an MMCT donor.
 Since CHO cells were reported to respond to VD3 
stimulation through VD3 receptor expression,17 we next 
tested the OC-Luc reporter activity in the CHO cells (Fig. 
2B). VD3 treatment induced Luc activity that confirmed 
the responsiveness of the OC regulatory sequence in 
the OC-Luc/Mac4 vector in the CHO background. Two 
CHO clones (#4 and #17) were arbitrarily chosen as the 
donor cells for the transfer of the OC-Luc/MAC4 vector 
to the human MSC cells. From CHO clone #4, the OC-
Luc/MAC4 vector was once transferred by MMCT to 
mouse A9 cells that were used as intermediate host cells 
because of being highly competent to produce micronu-
clei.
Transfer of the OC-Luc/MAC4 reporter vector to a 
mesenchymal stem cell line
A mesenchymal stem cell line hiMSC, which retains 
differentiation potential to osteogenic lineages12 pro-
vided recipient cells for the assessment of the OC-Luc/
MAC4 reporter vector. To utilize the reconstructed 
HPRT gene as a selection marker for MMCT, an HPRT– 
subline established by 6-thioguanine selection was used. 
From the donor cells (A9#4 and CHO#17), MMCT was 
carried out to the hiMSC (HPRT–) cells. As a result of 
HAT selection culture, five and one HPRTr hybrids were 
obtained from the two OC-Luc/MAC4 donor clones #4 
and #17, respectively. Retention of the OC-Luc/MAC4 
was addressed by FISH analysis (Fig. 3A).  Karyotypes 
of the metaphase spreads were not necessarily uniform 
and a few variations were observed (data not shown). 
Since the extent of the variation differed among the 
clones, we chose the two hiMSC clones (#4 and #17) 
showing the highest retention score (over 40%) of a 
single copy MAC without host chromosome integration.
Evaluation of the OC-Luc/MAC4 reporter vector in 
the mesenchymal stem cell hybrids
As differentiation potential is a prerequisite for monitor-
ing the transcriptional regulation of the OC-Luc reporter 
gene, the hiMSC hybrids were cultured in osteogenic 
differentiation medium, which contains DEX, ascorbic 
acid and beta-glycerophosphate.3 During osteogenic 
differentiation of MSCs, ALP activity is upregulated in 
the early stage.7 ALP activity was addressed by histo-
chemical staining assay at day 7 (Fig. 3B). In the hiMSC 
hybrid cells, qualitative difference in ALP activity be-
tween DEX treated and untreated culture was detected, 
indicating that the hiMSC hybrid cells retain osteogenic 
differentiation potential.
 Next, the hiMSC hybrid cells were tested for their 
OC-Luc activity in response to a given stimulation. As 
agonistic and antagonistic compounds for the OC tran-
scription, VD3 and DEX were used, respectively (Fig. 4). 
While culture for 7 days in differentiation medium with 
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VD3 in either growth medium or differentiation medium 
affected the induction of Luc activity. These results sup-
port the previously reported effects of VD3 and DEX for 
OC transcriptional regulation in the early stage of osteo-
genic differentiation of human MSCs.3, 18 It was noted 
that combined application of VD3 to the DEX medium 
exceeded the extent of activation by VD3 treatment 
alone, suggesting a synergistic effect of differentiation 
induction and VD3.
 The MAC4 vector is equipped with the EGFP gene 
under the regulation of CAG promoter (Fig. 1A). GFP 
fluorescence was consistently observed regardless of cul-
ture medium compositions and added supplements (data 
not shown), indicating the utility of GFP as an internal 
control for the evaluation by the OC-Luc reporter sys-
tem.
DISCUSSION
In addition to its role in systemic calcium homeostasis, 
VD3 affects cell proliferation, differentiation and func-
tion of cells expressing the vitamin D receptor.19 VD3 
was reported to enhance the differentiation of hMSCs to 
osteoblasts, suggesting a potential autocrine/paracrine 
role of VD3 in osteoblast differentiation.20 On the con-
trary, DEX contained in the osteogenic differentiation 
medium3 negatively regulates OC transcription through 
glucocolticoid receptor during osteogenic lineage com-
mitment of MSCs.21 It was also reported that gluco-
colticoid receptor binding interfered with the OC basal 
promoter.22 In the present study, we showed that OC-
Luc activity in the MSC hybrid cells was stimulated by 
VD3 and restrained by DEX. These results suggest that 
the OC-Luc reporter construct is faithfully regulated by 
positive and negative stimulation during the differentia-
tion of MSCs.
 Comparison of VD3 and DEX effects on OC in-
duction was reported in human marrow stromal cells.18 
The report demonstrated no apparent induction of OC 
mRNA expression by DEX, moderate induction by VD3 
and prominent induction by combined application of 
DEX and VD3. For the screening of substances using 
our OC-Luc reporter cells system, four culture medium 
compositions are supposed, i.e. the MSC growth medi-
um with or without VD3 and the osteogenic differentia-
tion medium containing DEX with or without VD3. De-
tection of OC-Luc activation in the media without VD3 
may be read as identifying the substitution for DEX or 
novel differentiation inducer. In the media with VD3, it 
is expected that the synergistic enhancer for VD3 has 
been found.
 In addition to optimizing the composition of culture 
medium, control of stem cell fate has been explored in 
the aspect of signal transduction by adhesion and mech-
anosensory stimuli from the extracellular matrix and 
substratum. Integrin-dependent cellular interactions with 
the extracellular matrix could control the differentiation 
of stem cells.23 Another report described that the elastic-
ity of the underlying substratum influences the differ-
entiation of MSCs.24  Moreover, surface characteristics 
of substratum, like topography, surface chemistry and 
surface energy, are critical parameters for the adhesion 
of stem cells to biomaterials and for differentiation into 
the osteogenic lineage. In the development of new mate-
rials for medical implants, these parameters have to be 
taken into account.25 The OC-Luc/MAC repoter system 
may be applicable for evaluation of biophysical signaling 
from culture substratum.
 In this study, we established an evaluation system, 
which can trace differentiation of MSCs toward osteo-
blast by monitoring Luc activity under the control of OC 
gene regulatory sequences. By utilizing this system, the 
ability of a given chemical and/or physical stimulation 
to either facilitate or retard osteoblastic differentiation 
could be monitored in a time-dependent manner. Con-
sequently, our approach could offer a qualified tool for 
temporal monitoring of osteogenesis in studies dealing 
with drug screening and tissue engineering.
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Fig. 4. Responsiveness of the OC-Luc activity was tested against 
VD3 treatment and osteogenic induction medium containing 
DEX. Effect of VD3 addition (10 nM) was tested in culture medi-
um (C) and osteogenic induction medium (OD) at day 7. Data are 
expressed by mean values and distribution range from duplicate 
experiment. 
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